EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption

Isabel Losada-Castillo, Isolina Santiago-Pérez, Ana Isabel García-Vallejo, Lucía Martinez-Lamas, María Dolores Formoso Lavandeira, Raquel Vázquez-Mourelle

Enfermedades infecciosas y microbiologia clinica (English ed.) · 2026-11 · 44 (9) · 503264

DOI: 10.1016/j.eimce.2026.503264 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2026-11. Verfasst von Isabel Losada-Castillo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servizo de Calidade e Procesos de Soporte Asistenciais, SDX de Atención Hospitalaria, Servizo Galego de Saude, Consellería de Sanidade, Xunta de Gali…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Urinary Tract Infections, Escherichia coli, Escherichia coli Infections. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The objective of this study was to describe antimicrobial resistance patterns of Escherichia coli isolated from urine samples in primary care and to identify trends relevant to empirical treatment of urinary tract infections. METHODS: We conducted an observational, retrospective, multicenter study including 49,746 E. coli isolates from urine samples obtained between January 2023 and December 2024 in ten hospital microbiology laboratories in Galicia, Spain. Antimicrobial susceptibility testing followed EUCAST guidelines. Resistance rates were analyzed by age, sex, and temporal trends. Outpatient antibiotic consumption data from the Galician Health Service (2015-2024) were reviewed to correlate associations with resistance patterns. RESULTS: E. coli was more frequently isolated in women, with higher rates in older adults. Resistance to amoxicillin-clavulanic acid increased compared with 2016-2017, whereas resistance to ciprofloxacin and trimethoprim-sulfamethoxazole declined. Fosfomycin resistance remained stable, and nitrofurantoin resistance appeared lower, likely reflecting updated breakpoints. Multidrug resistance was uncommon (3.37% for cefotaxime+ciprofloxacin+trimethoprim-sulfamethoxazole; 1% for cefotaxime+ciprofloxacin+trimethoprim-sulfamethoxazole+gentamicin). In two hospitals, ESBL-producing isolates showed significantly higher resistance to fosfomycin (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsUrinary Tract InfectionsEscherichia coliEscherichia coli InfectionsDrug Resistance, BacterialDrug UtilizationHumansSpainFemaleRetrospective StudiesPrimary Health CareAgedMaleMiddle AgedAdultAdolescentYoung AdultChildChild, PreschoolAged, 80 and overMicrobial Sensitivity TestsInfant

Stichwörter der Autor:innen

Antimicrobial resistanceAtención primariaCistitisCystitisEpidemiologyEpidemiologíaEscherichia coliPrimary careResistencia antimicrobianaSensibilidad antibióticaSusceptibility testing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Servizo de Calidade e Procesos de Soporte Asistenciais, SDX de Atención Hospitalaria, Servizo Galego de Saude, Consellería de Sanidade, Xunta de Galicia, Spain. Electronic address: isabel.losada.castillo@sergas.es.
  • Servizo de Información de Saúde, Dirección Xeral de Saúde Pública, Consellería de Sanidade, Xunta de Galicia, Spain.
  • Servizo de Xestión de Proxectos de Sistemas de Información e Innovación Dixital, Subdirección Xeral de Sistemas e Tecnoloxías da Información, Consellería de Sanidade, Xunta de Galicia, Spain.
  • Servizo de Microbiología, Complexo Hospitalario Universitario de Santiago de Compostela, Spain.
  • Servizo de Calidade e Procesos de Soporte Asistenciais, SDX de Atención Hospitalaria, Servizo Galego de Saude, Consellería de Sanidade, Xunta de Galicia, Spain.

Zitieren

APA

Losada-Castillo, I., Santiago-Pérez, I., García-Vallejo, A. I., Martinez-Lamas, L., Formoso Lavandeira, M. D., & Vázquez-Mourelle, R. (2026). Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption. Enfermedades infecciosas y microbiologia clinica (English ed.), 44(9), 503264. https://doi.org/10.1016/j.eimce.2026.503264

Vancouver

Losada-Castillo I, Santiago-Pérez I, García-Vallejo AI, Martinez-Lamas L, Formoso Lavandeira MD, Vázquez-Mourelle R. Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption. Enfermedades infecciosas y microbiologia clinica (English ed.). 2026;44(9):503264. doi:10.1016/j.eimce.2026.503264

BibTeX
@article{LosadaCastillo2026,
  author = {Losada-Castillo, Isabel and Santiago-Pérez, Isolina and García-Vallejo, Ana Isabel and Martinez-Lamas, Lucía and Formoso Lavandeira, María Dolores and Vázquez-Mourelle, Raquel},
  title = {Antimicrobial resistance in Escherichia coli urinary isolates from primary care in Galicia (Spain), 2023–2024: Trends and relationship with antibiotic consumption},
  journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
  year = {2026},
  volume = {44},
  number = {9},
  pages = {503264},
  doi = {10.1016/j.eimce.2026.503264}
}
Kostenlos starten →